7910 Woodmont Avenue,Suite 1210
Bethesda, Maryland 20814, U.S.A. 
info@mlsvfund.com |   +1 301 298 5455

© 2018  by MASA Life Science Ventures, LP

Apellis Reports Positive Top-line Results from Phase 3 Head-to-Head Study of Pegcetacoplan (APL-2) Compared to Eculizumab in Patients with Paroxysmal...

January 7, 2020

Please reload

Featured Posts

Cytox Congratulates Professor John Hardy, First UK Winner of $3m Breakthrough Prize in Life Sciences

November 11, 2015

Oxford, United Kingdom - Cytox congratulates Professor John Hardy (UCL Institute of Neurology, London) on receiving the $3 million (Ł2 million) Breakthrough Prize in Life Sciences for his pioneering research into the genetic causes of Alzheimer’s disease, other forms of dementia and Parkinson’s disease. The Breakthrough Prize in Life Sciences honours ‘transformative advances toward understanding living systems and extending human life’. This is the first time that the prize has been awarded to a UK researcher.

‘We are proud to be associated with John Hardy’, commented Richard Pither, CEO Cytox Ltd, ‘He is a much valued member of our Scientific Advisory Panel, and is a key part of the consortium we lead that was awarded Innovate UK funding earlier this year to investigate the application of SNP profiling to risk stratification in Alzheimer’s disease.’

The Breakthrough Prize is backed by Facebook chief executive Mark Zuckerberg and Google co-founder Sergey Brin, among others.





Please reload